The Global Diabetes Drug Market is anticipated to be almost US$107.02 billion by 2032, up from US$63.02 billion in 2023. The CAGR for the market from 2024 to 2032 is 6.06%.
Diabetes is a chronic metabolic disorder characterized by high blood sugar levels resulting from either insufficient insulin production or ineffective use of insulin by the body. With over 460 million people affected worldwide, diabetes has become a significant public health concern, particularly in low- and middle-income countries.
An excessively high blood glucose, or blood sugar, level is known as diabetes. The meals people eat provide them with glucose. Glucose is a necessary energy source for bodily cells. Insulin is a hormone that facilitates the uptake of glucose into the cells. Insulin is a diabetes medication that people with type 1 diabetes must take to manage their blood sugar. Some individuals with type 2 diabetes can manage their blood sugar with physical activity and a nutritious diet. For some, th